CD8 T cells require gamma interferon to clear Borna disease virus from the brain and prevent immune system-mediated neuronal damage

Journal of Virology

Volumn 79, Issue 21, 2005, Pages 13509-13518

  Hausmann, Jürgen ^a,c   Pagenstecher, Axel ^a   Baur, Karen ^a   Richter, Kirsten ^a   Rziha, Hanns Joachim ^b   Staeheli, Peter ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b FEDERAL RESEARCH INSTITUTE FOR ANIMAL HEALTH   (Germany)

^c Bavarian Nordic GmbH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CCL1 CHEMOKINE; CD8 ANTIGEN; CHEMOKINE; EOTAXIN; GAMMA INTERFERON; INTERLEUKIN 13; NUCLEOPROTEIN; NUCLEOPROTEIN N; UNCLASSIFIED DRUG;

AGE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BORNA DISEASE VIRUS; BRAIN INFECTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENCEPHALITIS; EOSINOPHIL; HIPPOCAMPUS; HOST RESISTANCE; INFECTION SENSITIVITY; MENINGOENCEPHALITIS; MOUSE; NERVE CELL LESION; NEUROPROTECTION; NONHUMAN; PERSISTENT INFECTION; PRIORITY JOURNAL; T LYMPHOCYTE; VACCINATION; VIRUS RESISTANCE;

AGE FACTORS; ANIMALS; BORNA DISEASE; BORNA DISEASE VIRUS; BRAIN; CD8-POSITIVE T-LYMPHOCYTES; CHEMOKINES; CYTOTOXICITY TESTS, IMMUNOLOGIC; EOSINOPHILS; GENETIC VECTORS; INJECTIONS, INTRAMUSCULAR; INTERFERON TYPE II; INTERLEUKIN-13; MICE; MICE, KNOCKOUT; NERVOUS SYSTEM DISEASES; NUCLEOCAPSID PROTEINS; PARAPOXVIRUS; SPLEEN; VACCINATION; VACCINES, SYNTHETIC; VACCINIA VIRUS; VIRAL VACCINES;

BORNA DISEASE VIRUS;

EID: 27144536528     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.79.21.13509-13518.2005     Document Type: Article

References (72)

1. Andersson, T., M. Schultzberg, R. Schwarcz, A. Love, C. Wickman, and K. Kristensson. 1991. NMDA receptor antagonist prevents measles virus-induced neurodegeneration. Eur. J. Neurosci. 3:66-71.
2. Andersson, T., R. Schwarcz, A. Love, and K. Kristensson. 1993. Measles virus-induced hippocampal neurodegeneration in the mouse: a novel, subacute model for testing neuroprotective agents. Neurosci. Lett. 154:109-112.
3. Barish, M. E., N. B. Mansdorf, and S. S. Raissdana. 1991. Gamma-interferon promotes differentiation of cultured cortical and hippocampal neurons. Dev. Biol. 144:412-423.
4. Batra, A., O. Planz, T. Bilzer, and L. Stitz. 2003. Precursors of Borna disease virus-specific T cells in secondary lymphatic tissue of experimentally infected rats. J. Neurovirol. 9:325-335.
5. Ben-Ari, Y., and R. Cossart. 2000. Kainate, a double agent that generates seizures: two decades of progress. Trends Neurosci. 23:580-587.
6. Benedikz, E., P. Casaccia-Bonnefil, A. Stelzer, and P. J. Bergold. 1993. Hyperexcitability and cell loss in kainate-treated hippocampal slice cultures. Neuroreport 5:90-92.
7. Bergmann, C. C., B. Parra, D. R. Hinton, C. Ramakrishna, K. C. Dowdell, and S. A. Stohlman. 2004. Perform and gamma interferon-mediated control of coronavirus central nervous system infection by CD8 T cells in the absence of CD4 T cells. J. Virol. 78:1739-1750.
8. Binder, G. K., and D. E. Griffin. 2001. Interferon-gamma-mediated site-specific clearance of alphavirus from CNS neurons. Science 293:303-306.
9. Boehm, U., T. Klamp, M. Groot, and J. C. Howard. 1997. Cellular responses to interferon-gamma. Annu. Rev. Immunol. 15:749-795.
10. Broide, D., and P. Sriramarao. 2001. Eosinophil trafficking to sites of allergic inflammation. Immunol. Rev. 179:163-172.
11. Chang, J. Y., D. P. Martin, and E. M. Johnson, Jr. 1990. Interferon suppresses sympathetic neuronal cell death caused by nerve growth factor deprivation. J. Neurochem. 55:436-445.
12. Dalton, D. K., S. Pitts-Meek, S. Keshav, I. S. Figari, A. Bradley, and T. A. Stewart. 1993. Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science 259:1739-1742.
13. Dawson, V. L., and T. M. Dawson. 1996. Nitric oxide neurotoxicity. J. Chem. Neuroanat. 10:179-190.
14. Engelhardt, K. R., K. Richter, K. Baur, P. Staeheli, and J. Hausmann. 2005. The functional avidity of virus-specific CD8+ T cells is down-modulated in Borna disease virus-induced immunopathology of the central nervous system. Eur. J. Immunol. 35:487-497.
15. Fassnacht, U., A. Ackermann, P. Staeheli, and J. Hausmann. 2004. Immunization with dendritic cells can break immunological ignorance toward a persisting virus in the central nervous system and induce partial protection against intracerebral viral challenge. J. Gen. Virol. 85:2379-2387.
16. Ferber, I. A., S. Brocke, C. Taylor-Edwards, W. Ridgway, C. Dinisco, L. Steinman, D. Dalton, and C. G. Fathman. 1996. Mice with a disrupted IFN-gamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). J. Immunol. 156:5-7.
17. Fleming, J. O., R. A. Shubin, M. A. Sussman, N. Casteel, and S. A. Stohlman. 1989. Monoclonal antibodies to the matrix (E1) glycoprotein of mouse hepatitis virus protect mice from encephalitis. Virology 168:162-167.
18. Friedl, G., M. Hofer, B. Auber, C. Sauder, J. Hausmann, P. Staeheli, and A. Pagenstecher. 2004. Borna disease virus multiplication in mouse organotypic slice cultures is site-specifically inhibited by gamma interferon but not by interleukin-12. J. Virol. 78:1212-1218.
19. Fujinami, R. S., A. Rosenthal, P. W. Lampert, A. Zurbriggen, and M. Yamada. 1989. Survival of athymic (nu/nu) mice after Theiler's murine encephalomyelitis virus infection by passive administration of neutralizing monoclonal antibody. J. Virol. 63:2081-2087.
20. Furrer, E., T. Bilzer, L. Stitz, and O. Planz. 2001. High-dose Borna disease virus infection induces a nucleoprotein-specific cytotoxic T-lymphocyte response and prevention of immunopathology. J. Virol. 75:11700-11708.
21. Gimsa, U., S. V. Peter, K. Lehmann, I. Bechmann, and R. Nitsch. 2000. Axonal damage induced by invading T cells in organotypic central nervous system tissue in vitro: involvement of microglial cells. Brain Pathol. 10:365-377.
22. Goelz, M. F., J. Mahler, J. Harry, P. Myers, J. Clark, J. E. Thigpen, and D. B. Forsythe. 1998. Neuropathologic findings associated with seizures in FVB mice. Lab. Anim. Sci. 48:34-37.
23. Gosztonyi, G., and H. Ludwig. 1995. Borna disease-neuropathology and pathogenesis. Curr. Top. Microbiol. Immunol. 190:39-73.
24. k-restricted T-cell epitopes within the influenza A/PR/8/34 virus hemagglutinin. J. Virol. 65:5401-5409.
25. Hallensieben, W., M. Schwemmle, J. Hausmann, L. Stitz, B. Volk, A. Pagenstecher, and P. Staeheli. 1998. Borna disease virus-induced neurological disorder in mice: infection of neonates results in immunopathology. J. Virol. 72:4379-4386.
26. Hausmann, J., K. Baur, K. Engelhardt, T. Fischer, H. Rziha, and P. Staeheli. 2005. Vaccine-induced protection against Borna disease of wild-type and perforin-deficient mice. J. Gen. Virol. 86:399-403.
27. Hausmann, J., W. Hallensleben, J. C. de la Torre, A. Pagenstecher, C. Zimmermann, H. Pircher, and P. Staeheli. 1999. T cell ignorance in mice to Borna disease virus can be overcome by peripheral expression of the viral nucleoprotein. Proc. Natl. Acad. Sci. USA 96:9769-9774.
28. Hausmann, J., C. Sauder, M. Wasmer, B. Lu, and P. Staeheli. 2004. Neurological disorder after Borna disease virus infection in the absence of either interferon-gamma, Fas, inducible NO synthase, or chemokine receptor CXCR3. Viral Immunol. 17:79-85.
29. Heller, N. M., S. Matsukura, S. N. Georas, M. R. Boothby, P. B. Rothman, C. Stellate, and R. P. Schleimer. 2004. Interferon-gamma inhibits STAT6 signal transduction and gene expression in human airway epithelial cells. Am. J. Respir. Cell. Mol. Biol. 31:573-582.
30. Heneka, M. T., and D. L. Feinstein. 2001. Expression and function of inducible nitric oxide synthase in neurons. J. Neuroimmunol. 114:8-18.
31. Henkel, M., O. Planz, T. Fischer, L. Stitz, and H. J. Rziha. 2005. Prevention of virus persistence and protection against immunopathology after Borna disease virus infection of the brain by a novel Orf virus recombinant. J. Virol. 79:314-325.
32. Hofer, M., J. Hausmann, P. Staeheli, and A. Pagenstecher. 2004. Cerebral expression of interleukin-12 induces neurological disease via differential pathways and recruits antigen-specific T cells in virus-infected mice. Am. J. Pathol. 165:949-958.
33. Horwitz, M. S., C. F. Evans, F. G. Klier, and M. B. Oldstone. 1999. Detailed in vivo analysis of interferon-gamma induced major histocompatibility complex expression in the central nervous system: astrocytes fail to express major histocompatibility complex class I and II molecules. Lab. Investig. 79:235-242.
34. Hu, X., H. Ho, O. Um, C. Hidaka, and L. B. Ivashkiv. 2005. Homeostatic role of interferons conferred by inhibition of IL-1-mediated inflammation and tissue destruction. J. Immunol. 175:131-138.
35. Komatsu, T., Z. Bi, and C. S. Reiss. 1996. Interferon-gamma induced type I nitric oxide synthase activity inhibits viral replication in neurons. J. Neuroimmunol. 68:101-108.
36. Kundig, T. M., H. Hengartner, and R. M. Zinkernagel. 1993. T cell-dependent IFN-gamma exerts an antiviral effect in the central nervous system but not in peripheral solid organs. J. Immunol. 150:2316-2321.
37. Levine, B., J. M. Hardwick, B. D. Trapp, T. O. Crawford, R. C. Bollinger, and D. E. Griffin. 1991. Antibody-mediated clearance of alphavirus infection from neurons. Science 254:856-860.
38. Lewis, A. J., J. L. Whitton, C. G. Hatalski, H. Weissenbock, and W. I. Lipkin. 1999. Effect of immune priming on Borna disease. J. Virol. 73:2541-2546.
39. Li, L., Y. Xia, A. Nguyen, Y. H. Lai, L. Feng, T. R. Mosmann, and D. Lo. 1999. Effects of Th2 cytokines on chemokine expression in the lung: IL-13 potently induces eotaxin expression by airway epithelial cells. J. Immunol. 162:2477-2487.
40. Liu, T., K. M. Khanna, B. N. Carriere, and R. L. Heridricks. 2001. Gamma interferon can prevent herpes simplex virus type 1 reactivation from latency in sensory neurons. J. Virol. 75:11178-11184.
41. Lo Re, V., III, and S. J. Gluckman. 2003. Eosinophilic meningitis. Am. J. Med. 114:217-223.
42. Matsukura, S., C. Stellate, S. N. Georas, V. Casolaro, J. R. Plitt, K. Miura, S. Kurosawa, U. Schindler, and R. P. Schleimer. 2001. Interleukin-13 upregulates eotaxin expression in airway epithelial cells by a STAT6-dependent mechanism. Am. J. Respir. Cell. Mol. Biol. 24:755-761.
43. Moalem, G., R. Leibowitz-Amit, E. Yoles, F. Mor, I. R. Cohen, and M. Schwartz. 1999. Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy. Nat. Med. 5:49-55.
44. Narayan, O., S. Herzog, K. Frese, H. Scheefers, and R. Rott. 1983. Behavioral disease in rats caused by immunopathological responses to persistent Borna virus in the brain. Science 220:1401-1403.
45. Nargi-Aizenman, J. L., M. B. Havert, M. Zhang, D. N. Irani, J. D. Rothstein, and D. E. Griffin. 2004. Glutamate receptor antagonists protect from virus-induced neural degeneration. Ann. Neurol. 55:541-549.
46. Oliveira, S. H., S. Lira, A. C. Martinez, M. Wiekowski, L. Sullivan, and N. W. Lukacs. 2002. Increased responsiveness of murine eosinophils to MIP-1beta (CCL4) and TCA-3 (CCL1) is mediated by their specific receptors, CCR5 and CCR8. J. Leukoc. Biol. 71:1019-1025.
47. Panitch, H. S., R. L. Hirsch, A. S. Haley, and K. P. Johnson. 1987. Exacerbations of multiple sclerosis in patients treated with gamma interferon. Lancet i(8538):893-895.
48. Parra, B., D. R. Hinto, N. W. Marten, C. C. Bergmann, M. T. Lin, C. S. Yang, and S. A. Stohlman. 1999. IFN-gamma is required for viral clearance from central nervous system oligodendroglia. J. Immunol. 162:1641-1647.
49. Patterson, C. E., D. M. Lawrence, L. A. Echols, and G. F. Rall. 2002. Immune-mediated protection from measles virus-induced central nervous system disease is noncytolytic and gamma interferon dependent. J. Virol. 76:4497-4506.
50. Pearce, B. D., M. V. Hobbs, T. S. McGraw, and M. J. Buchmeier. 1994. Cytokine induction during T-cell-mediated clearance of mouse hepatitis virus from neurons in vivo. J. Virol. 68:5483-5495.
51. + T cells in murine resistance to street rabies virus. J. Virol. 65:3429-3434.
52. Popko, B., J. G. Corbin, K. D. Baenvald, J. Dupree, and A. M. Garcia. 1997. The effects of interferon-gamma on the central nervous system. Mol. Neurobiol. 14:19-35.
53. Renno, T., V. Taupin, L. Bourbonniere, G. Verge, E. Tran, R. De Simone, M. Krakowski, M. Rodriguez, A. Peterson, and T. Owens. 1998. Interferon-gamma in progression to chronic demyelination and neurological deficit following acute EAE. Mol. Cell. Neurosci. 12:376-389.
54. Richt, J. A., A. Schmeel, K. Frese, K. M. Carbone, O. Narayan, and R. Rott. 1994. Borna disease virus-specific T cells protect against or cause immunopathological Borna disease. J. Exp. Med. 179:1467-1473.
55. Robertson, B., G. Kong, Z. Peng, M. Bentivoglio, and K. Kristensson. 2000. Interferon-gamma-responsive neuronal sites in the normal rat brain: receptor protein distribution and cell activation revealed by Fos induction. Brain Res. Bull. 52:61-74.
56. Rodriguez, M., L. J. Zoecklein, C. L. Howe, K. D. Pavelko, J. D. Gamez, S. Nakane, and L. M. Papke. 2003. Gamma interferon is critical for neuronal viral clearance and protection in a susceptible mouse strain following early intracranial Theiler's murine encephalomyelitis virus infection. J. Virol. 77:12252-12265.
57. Rodriguez-Moreno, A., J. C. Lopez-Garcia, and J. Lerma. 2000. Two populations of kainate receptors with separate signaling mechanisms in hippocampal interneurons. Proc. Natl. Acad. Sci. USA 97:1293-1298.
58. Rott, R., and H. Becht. 1995. Natural and experimental Borna disease in animals. Curr. Top. Microbiol. Immunol. 190:17-30.
59. Sauder, C., I. Herpfer, C. Hassler, and P. Staeheli. 2004. Susceptibility of Borna disease virus to the antiviral action of gamma-interferon: evidence for species-specific differences. Arch. Virol. 149:2171-2186.
60. k-restricted cytotoxic T-cell epitope in the Borna disease virus nucleoprotein. J. Virol. 75:8579-8588.
61. Shaked, I., D. Tchoresh, R. Gersner, G. Meiri, S. Mordechai, X. Xiao, R. P. Hart, and M. Schwartz. 2005. Protective autoimmunity: interferon-gamma enables microglia to remove glutamate without evoking inflammatory mediators. J. Neurochem. 92:997-1009.
62. Shen, H. H., S. I. Ochkur, M. P. McGarry, J. R. Crosby, E. M. Hines, M. T. Borchers, H. Wang, T. L. Biechelle, K. R. O'Neill, T. L. Ansay, D. C. Colbert, S. A. Cormier, J. P. Justice, N. A. Lee, and J. J. Lee. 2003. A causative relationship exists between eosinophils and the development of allergic pulmonary pathologies in the mouse. J. Immunol. 170:3296-3305.
63. Staeheli, P., C. Sauder, J. Hausmann, F. Ehrensperger, and M. Schwemmle. 2000. Epidemiology of Borna disease virus. J. Gen. Virol. 81:2123-2135.
64. Stitz, L., T. Bilzer, and O. Planz. 2002. The immunopathogenesis of Borna disease virus infection. Front. Biosci. 7:d541-d555.
65. Tishon, A., H. Lewicki, G. Rail, M. Von Herrath, and M. B. Oldstone. 1995. An essential role for type 1 interferon-gamma in terminating persistent viral infection. Virology 212:244-250.
66. Tran, E. H., E. N. Prince, and T. Owens. 2000. IFN-gamma shapes immune invasion of the central nervous system via regulation of chemokines. J. Immunol. 164:2759-2768.
67. Trapani, J. A., and M. J. Smyth. 2002. Functional significance of the perforin/granzyme cell death pathway. Nat. Rev. Immunol. 2:735-747.
68. van den Broek, M., M. F. Bachmann, G. Kohler, M. Barner, R. Escher, R. Zinkernagel, and M. Kopf. 2000. IL-4 and IL-10 antagonize IL-12-mediated protection against acute vaccinia virus infection with a limited role of IFN-gamma and nitric oxide synthetase 2. J. Immunol. 164:371-378.
69. Weidinger, G., G. Henning, V. ter Meulen, and S. Niewiesk. 2001. Inhibition of major histocompatibility complex class II-dependent antigen presentation by neutralization of gamma Interferon leads to breakdown of resistance against measles virus-induced encephalitis. J. Virol. 75:3059-3065.
70. Willenborg, D. O., S. Fordham, C. C. Bernard, W. B. Cowden, and I. A. Ramshaw. 1996. IFN-gamma plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. J. Immunol. 157:3223-3227.
71. Young, H. A., and K. J. Hardy. 1995. Role of interferon-gamma in immune cell regulation. J. Leukoc. Biol. 58:373-381.
72. Zucker-Franklin, D., and G. Grusky. 1976. The identification of eosinophil colonies in soft-agar cultures by differential staining for peroxidase. J. Histochem. Cytochem. 24:1270-1272.